Welcome international healthcare professionals

This site is no longer supported and will not be updated with new content. You are welcome to browse and download all content already included in the site. Please note you will have to register your email address to access the site.

You are here

Preoperative and pretreatment investigations for malignant melanoma

Alberta Provincial Cutaneous Tumour Team.

Alberta Health Services, Cancer Care; 2012 Mar. 8 p. (Clinical practice guideline; no. CU-007). 


Potential Benefits

Pre-operative or pre-treatment investigations in patients with malignant melanoma are important for establishing baseline values, confirming or re-evaluating treatment plans, or possibly identifying patients who may be suitable for inclusion in a clinical trial.

Potential Harms

In general, care must be taken when interpreting the results of blood or imaging tests, given the relatively low sensitivity of some of these tests.


Qualifying Statements

The recommendations contained in this guideline are a consensus of the Alberta Provincial Cutaneous Tumour Team and are a synthesis of currently accepted approaches to management, derived from a review of relevant scientific literature. Clinicians applying these guidelines should, in consultation with the patient, use independent medical judgment in the context of individual clinical circumstances to direct care.